Crystal Structure of CB1 and MDMB-Fubinaca Gives Insight Into Synthetic Cannabinoids’ Potency
Stronger binding interactions between MDMB-Fubinaca and CB1 may explain why some synthetic cannabinoids cause dangerous effects.
Scientific Research - Page 14
Crystal Structure of LSD and 5-HT2AR- Part 1: Capturing the First Steps of a Psychedelic Trip
High-resolution structure reveals how LSD binds to and activates the canonical mind-altering receptor.
LSD, Music, and the Mysteries of Consciousness
Connectome-Specific Harmonic Waves: A new way of looking at the brain sheds light on the biological correlates of consciousness.
UC Berkeley Opens the Center for the Science of Psychedelics
"There's never been a better time to start a center like this."
MDMA, PTSD, and Potentially Overlooked Positive Outcomes
Measuring and increasing post-traumatic growth may lead to more rewarding interpersonal relationships, self-esteem, and a more optimistic outlook on life.
Ayahuasca Impacts the Big 5 Personality Traits
Research indicates that ayahuasca promotes sustained decreases in neuroticism and increases in agreeableness and openness.
Figuring Out a Mouse-Sized Dose of LSD
For humans, drug doses are based largely on body weight. But in animals, differences in brain and body chemistry make the calculations far more complicated.
Scientists Use Psychedelics to Discover an Anti-Inflammatory Pharmacophore
Integrating several tests into a SAR, scientists have identified the compound 2C-H as a structural basis of the anti-inflammatory response in rats.
Cybin’s Sublingual Psilocybin Strips Head to Clinical Trials for Dose-Finding
The first trial will determine the sublingual dose equivalent to 25 mg psilocybin administered orally.
MindMed and Liechti Lab to Conduct the First Clinical Trial Combining LSD and MDMA
Researchers will examine whether MDMA can offset some of the negative side effects of LSD in a therapeutic setting.